BEUDAMED
    FDA PMA 30-Day Notice Accepted 🇺🇸 United States

    PMA: P010031 · Supplement: S359 · Decision Mar 13, 2013
    View on FDA
    Classifications
    0
    FEI Numbers
    0
    Registration Numbers
    0

    Basic Information

    Trade Name
    CONSULTA DF4 ICD, MAXIMO II CRT-D, PROTECTA CRT-D, PROTECTA XT CRT-D
    PMA Number
    P010031
    Supplement Number
    S359
    Advisory Committee
    Cardiovascular
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    March 13, 2013
    Date Received
    February 15, 2013
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    ALTERNATE SUPPLIER OF A SILICONE COMPONENT.